These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2678873)

  • 21. A case of insulin resistant diabetes with possible antibodies to insulin receptors.
    Wasada T; Sakimoto T; Aso Y; Kato K; Ibayashi H; Omori Y
    Endocrinol Jpn; 1979 Feb; 26(1):19-26. PubMed ID: 436798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor-mediated endocytosis of [125I]insulin into pancreatic acinar cells in vivo.
    Cruz J; Posner BI; Bergeron JJ
    Endocrinology; 1984 Nov; 115(5):1996-2008. PubMed ID: 6386447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Defects in insulin binding, internalization and degradation of monocytes from patients with non-insulin-dependent diabetes mellitus].
    Li YX; Wang T; Zhang JC
    Zhonghua Nei Ke Za Zhi; 1993 Dec; 32(12):823-6. PubMed ID: 8033659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-induced surface redistribution regulates internalization of the insulin receptor and requires its autophosphorylation.
    Carpentier JL; Paccaud JP; Gorden P; Rutter WJ; Orci L
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):162-6. PubMed ID: 1729685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.
    Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R
    Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
    J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure of receptors and expression of anti-receptor antibodies. a. Insulin receptor antibodies].
    Kobayashi M
    Nihon Rinsho; 1988 Apr; 46(4):810-5. PubMed ID: 3043048
    [No Abstract]   [Full Text] [Related]  

  • 30. Retroendocytosis of insulin in rat adipocytes.
    Levy JR; Olefsky JM
    Endocrinology; 1986 Aug; 119(2):572-9. PubMed ID: 3525121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes mellitus caused by insulin-receptor blockade and impaired sensitivity to insulin.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Kromann H
    N Engl J Med; 1981 Apr; 304(18):1085-8. PubMed ID: 7010176
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients.
    Trischitta V; Gullo D; Pezzino V; Vigneri R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):713-8. PubMed ID: 6350337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
    Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
    Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normalization of the insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year.
    Beck-Nielsen H; Pedersen O; Lindskov HO
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):103-12. PubMed ID: 760352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endosome-lysosome transfer of insulin and glucagon in a liver cell-free system.
    Chauvet G; Tahiri K; Authier F; Desbuquois B
    Eur J Biochem; 1998 Jun; 254(3):527-37. PubMed ID: 9688263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A defect in cell-mediated immune function in insulin-resistant diabetic and obese subjects.
    Kolterman OG; Olefsky JM; Kurahara C; Taylor K
    J Lab Clin Med; 1980 Sep; 96(3):535-43. PubMed ID: 6995542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Production and internalization of extracellular vesicules in normal and under conditions of hyperglycemia and insulin resistance].
    Yunusova NV; Dandarova EE; Svarovsky DA; Denisov NS; Kostromitsky DN; Patysheva MR; Cheremisina OV; Spirina LV
    Biomed Khim; 2021 Nov; 67(6):465-474. PubMed ID: 34964440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.